2 results
Approved WMORecruiting
The primary objective is to compare invasive disease-free survival (IDFS) in patients with HER2-positive breast cancer randomized to chemotherapy plus one year of trastuzumab plus placebo or chemotherapy plus one year of trastuzumab plus pertuzumab…
Approved WMOCompleted
To study the effect of TRH on opioid-induced respiratory depression in healthy volunteers.